# XTL Biopharmaceuticals Ltd: Form 6-K, filed Oct 20, 2023

- Company: [XTL Biopharmaceuticals Ltd](/companies/xtlb.md) (CIK 1023549)
- Form: 6-K
- Filed: 2023-10-20
- Accepted by EDGAR: Oct 20, 2023, 20:00 ET
- Period: 2023-10-20
- Accession: 0001013762-23-005431
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1023549/000101376223005431/ea187052-6k_xtlbiopharma.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1023549/000101376223005431/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1023549/000101376223005431/ea187052-6k_xtlbiopharma.htm

Filed Oct 20, 2023.
Source: SEC EDGAR, the filing index for accession 0001013762-23-005431. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.
